![Ken Warrington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Warrington
Directeur/Membre du Conseil chez BIOSTEM TECHNOLOGIES INC
Fortune : - $ au 31/05/2024
Postes actifs de Ken Warrington
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOSTEM TECHNOLOGIES INC | Directeur/Membre du Conseil | 01/03/2022 | - |
Corporate Officer/Principal | 29/10/2019 | 01/03/2022 |
Historique de carrière de Ken Warrington
Anciens postes connus de Ken Warrington
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENSCRIPT PROBIO USA INC. | Corporate Officer/Principal | 01/01/2020 | 01/12/2021 |
Biostem Life Sciences, Inc. | Directeur des opérations | 01/06/2019 | 01/05/2020 |
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Directeur Technique/Scientifique/R&D | 01/11/2017 | 01/05/2019 |
Formation de Ken Warrington
The St. Lawrence College | Undergraduate Degree |
University of Florida | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOSTEM TECHNOLOGIES INC | Health Technology |
Entreprise privées | 3 |
---|---|
Biostem Life Sciences, Inc. | |
GENSCRIPT PROBIO USA INC. | |
Lacerta Therapeutics, Inc.
![]() Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Health Technology |
- Bourse
- Insiders
- Ken Warrington
- Expérience